Search Results

There are 3450 results for: content related to: Efficacy and Tolerability of Almotriptan in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Trial

  1. Effect of Early Intervention With Almotriptan vs Placebo on Migraine-Associated Functional Disability: Results From the AEGIS Trial

    Headache: The Journal of Head and Face Pain

    Volume 48, Issue 3, March 2008, Pages: 341–354, Frederick Freitag, Timothy Smith, Ninan Mathew, Marcia Rupnow, Steven Greenberg, Lian Mao, Gary Finlayson, Pamela Wright and David Biondi

    Article first published online : 24 JAN 2008, DOI: 10.1111/j.1526-4610.2007.01044.x

  2. How Does Almotriptan Compare With Other Triptans? A Review of Data From Placebo-Controlled Clinical Trials

    Headache: The Journal of Head and Face Pain

    Volume 42, Issue 2, February 2002, Pages: 99–113, Carl G.H. Dahlöf, David Dodick, Andrew J. Dowson and Julio Pascual

    Article first published online : 19 APR 2002, DOI: 10.1046/j.1526-4610.2002.02025.x

  3. Long-Term, Open-Label Safety Study of Oral Almotriptan 12.5 mg for the Acute Treatment of Migraine in Adolescents

    Headache: The Journal of Head and Face Pain

    Volume 50, Issue 5, May 2010, Pages: 795–807, Frank Berenson, Elza Vasconcellos, Ann Pakalnis, Lian Mao, David M. Biondi and Robert B. Armstrong

    Article first published online : 23 APR 2010, DOI: 10.1111/j.1526-4610.2010.01655.x

  4. Consistent Efficacy, Tolerability, and High Levels of Satisfaction With Almotriptan 12.5 mg When Used to Treat Multiple Migraine Attacks in Routine Clinical Practice

    Headache: The Journal of Head and Face Pain

    Volume 45, Issue 6, June 2005, Pages: 624–631, Hans-Christoph Diener

    Article first published online : 1 JUN 2005, DOI: 10.1111/j.1526-4610.2005.05129.x

  5. Almotriptan Versus Rizatriptan in Patients With Migraine in Spain

    Headache: The Journal of Head and Face Pain

    Volume 43, Issue 7, July 2003, Pages: 734–741, Rogelio Leira, Elena Dualde, Horacio Del Barrio, Manuel Machuca, Arturo López-Gil and Spanish Group for the Study of Triptan Consumption in Community Pharmacies

    Article first published online : 25 JUL 2003, DOI: 10.1046/j.1526-4610.2003.03131.x

  6. Early Intervention With Almotriptan: Results of the AEGIS Trial (AXERT® Early Migraine Intervention Study)

    Headache: The Journal of Head and Face Pain

    Volume 47, Issue 2, February 2007, Pages: 189–198, Ninan T. Mathew, Gary Finlayson, Timothy R. Smith, Roger K. Cady, James Adelman, Lian Mao, Pamela Wright, Steven J. Greenberg and on behalf of the AEGIS Investigator Study Group

    Article first published online : 13 FEB 2007, DOI: 10.1111/j.1526-4610.2006.00686.x

  7. Oral Sumatriptan and Almotriptan – Delimiting the MAOI Effect

    Headache: The Journal of Head and Face Pain

    Volume 52, Issue 5, May 2012, Pages: 765–772, Florian Oberhardt and Anthony W. Fox

    Article first published online : 21 MAR 2012, DOI: 10.1111/j.1526-4610.2012.02113.x

  8. Characteristics of Migraine Attacks and Responses to Almotriptan Treatment: A Comparison of Menstrually Related and Nonmenstrually Related Migraines

    Headache: The Journal of Head and Face Pain

    Volume 48, Issue 2, February 2008, Pages: 248–258, Merle L. Diamond, Roger K. Cady, Lian Mao, David M. Biondi, Gary Finlayson, Steven J. Greenberg and Pamela Wright

    Article first published online : 24 JAN 2008, DOI: 10.1111/j.1526-4610.2007.01019.x

  9. Meta-Analysis Examining the Efficacy and Safety of Almotriptan in the Acute Treatment of Migraine

    Headache: The Journal of Head and Face Pain

    Volume 47, Issue 8, September 2007, Pages: 1169–1177, Li-Chia Chen and Darren M. Ashcroft

    Article first published online : 19 SEP 2007, DOI: 10.1111/j.1526-4610.2007.00884.x

  10. Allodynia-Associated Symptoms, Pain Intensity and Time to Treatment: Predicting Treatment Response in Acute Migraine Intervention

    Headache: The Journal of Head and Face Pain

    Volume 49, Issue 3, March 2009, Pages: 350–363, Roger K. Cady, Frederick G. Freitag, Ninan T. Mathew, Arthur H. Elkind, Lian Mao, Alan C. Fisher, David M. Biondi, Gary Finlayson, Steven J. Greenberg and Joseph F. Hulihan

    Article first published online : 11 FEB 2009, DOI: 10.1111/j.1526-4610.2009.01340.x

  11. Almotriptan Increases Sustained Pain-Free Outcomes in Acute Migraine: Results From Three Controlled Clinical Trials

    Headache: The Journal of Head and Face Pain

    Volume 42, Issue 1, January 2002, Pages: 21–27, David W. Dodick

    Article first published online : 23 JAN 2002, DOI: 10.1046/j.1526-4610.2002.02009.x

  12. Almotriptan in Migraine Patients Who Respond Poorly to Oral Sumatriptan: A Double-Blind, Randomized Trial

    Headache: The Journal of Head and Face Pain

    Volume 45, Issue 7, July 2005, Pages: 874–882, Hans-Christoph Diener, Astrid Gendolla, Irmingard Gebert and Manfred Beneke

    Article first published online : 12 APR 2005, DOI: 10.1111/j.1526-4610.2005.05151.x

  13. Almotriptan Increases Pain-Free Status in Patients With Acute Migraine Treated in Placebo-Controlled Clinical Trials

    Headache: The Journal of Head and Face Pain

    Volume 42, Issue s1, January 2002, Pages: 32–37, Ninan T. Mathew

    Article first published online : 23 JAN 2002, DOI: 10.1046/j.1526-4610.2002.0420s1032.x

  14. Almotriptan Reduces the Incidence of Migraine-Associated Symptoms: A Pooled Analysis

    Headache: The Journal of Head and Face Pain

    Volume 42, Issue s1, January 2002, Pages: 26–31, Roger Cady

    Article first published online : 23 JAN 2002, DOI: 10.1046/j.1526-4610.2002.0420s1026.x

  15. A Long-term Open-Label Study of Oral Almotriptan 12.5 mg for the Treatment of Acute Migraine

    Headache: The Journal of Head and Face Pain

    Volume 42, Issue 1, January 2002, Pages: 32–40, Ninan T. Mathew and For The Oral Almotriptan Study Group

    Article first published online : 23 JAN 2002, DOI: 10.1046/j.1526-4610.2002.02011.x

  16. Effect of Pain Intensity and Time to Administration on Responsiveness to Almotriptan: Results from AXERT® 12.5 mg Time Versus Intensity Migraine Study (AIMS)

    Headache: The Journal of Head and Face Pain

    Volume 47, Issue 4, April 2007, Pages: 519–530, Frederick G. Freitag, Gary Finlayson, Alan M. Rapoport, Arthur H. Elkind, Merle L. Diamond, Jeffrey R. Unger, Alan C. Fisher, Robert B. Armstrong, Joseph F. Hulihan, Steven J. Greenberg and on behalf of the AIMS Investigators

    Article first published online : 13 APR 2007, DOI: 10.1111/j.1526-4610.2007.00756.x

  17. Tripstar: A Comprehensive Patient-Based Approach to Compare Triptans

    Headache: The Journal of Head and Face Pain

    Volume 42, Issue s1, January 2002, Pages: 18–25, Michel D. Ferrari

    Article first published online : 23 JAN 2002, DOI: 10.1046/j.1526-4610.2002.0420s1018.x

  18. Clinical Benefits of Early Triptan Therapy for Migraine

    Headache: The Journal of Head and Face Pain

    Volume 42, Issue s1, January 2002, Pages: 10–17, Julio Pascual

    Article first published online : 23 JAN 2002, DOI: 10.1046/j.1526-4610.2002.0420s1010.x

  19. Migraine Headache Recurrence: Relationship to Clinical, Pharmacological, and Pharmacokinetic Properties of Triptans

    Headache: The Journal of Head and Face Pain

    Volume 43, Issue 4, April 2003, Pages: 376–388, Gilles Géraud, Charlotte Keywood and Jean Michel Senard

    Article first published online : 27 MAR 2003, DOI: 10.1046/j.1526-4610.2003.03073.x

  20. Is There a Preferred Triptan?

    Headache: The Journal of Head and Face Pain

    Volume 42, Issue 1, January 2002, Pages: 1–7, David W. Dodick, Stephen Silberstein and Carl G. H. Dahlöf

    Article first published online : 23 JAN 2002, DOI: 10.1046/j.1526-4610.2002.02001.x